ATE230264T1 - Medizinische zusammensetzungen gegen helicobacter pylori - Google Patents
Medizinische zusammensetzungen gegen helicobacter pyloriInfo
- Publication number
- ATE230264T1 ATE230264T1 AT98919598T AT98919598T ATE230264T1 AT E230264 T1 ATE230264 T1 AT E230264T1 AT 98919598 T AT98919598 T AT 98919598T AT 98919598 T AT98919598 T AT 98919598T AT E230264 T1 ATE230264 T1 AT E230264T1
- Authority
- AT
- Austria
- Prior art keywords
- helicobacter pylori
- prevention
- infection
- pharmaceutical composition
- treatment
- Prior art date
Links
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 5
- 241000590002 Helicobacter pylori Species 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 abstract 3
- 208000007882 Gastritis Diseases 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- VLPYHCVEQZRLIJ-UHFFFAOYSA-N 1-hydroxy-3-methylquinolin-2-one Chemical class C1=CC=C2N(O)C(=O)C(C)=CC2=C1 VLPYHCVEQZRLIJ-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000589989 Helicobacter Species 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000008469 Peptic Ulcer Diseases 0.000 abstract 1
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000023652 chronic gastritis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000000718 duodenal ulcer Diseases 0.000 abstract 1
- 206010013864 duodenitis Diseases 0.000 abstract 1
- 206010017758 gastric cancer Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000003563 lymphoid tissue Anatomy 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000011549 stomach cancer Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
- C07D215/60—N-oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12746297 | 1997-05-16 | ||
| PCT/JP1998/002133 WO1998051306A1 (en) | 1997-05-16 | 1998-05-14 | Medicinal compositions against helicobacter pylori |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE230264T1 true ATE230264T1 (de) | 2003-01-15 |
Family
ID=14960536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98919598T ATE230264T1 (de) | 1997-05-16 | 1998-05-14 | Medizinische zusammensetzungen gegen helicobacter pylori |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6184230B1 (de) |
| EP (1) | EP0992241B1 (de) |
| KR (1) | KR100512516B1 (de) |
| CN (1) | CN1305472C (de) |
| AT (1) | ATE230264T1 (de) |
| AU (1) | AU7237698A (de) |
| CA (1) | CA2290549C (de) |
| DE (1) | DE69810474T2 (de) |
| ES (1) | ES2190076T3 (de) |
| WO (1) | WO1998051306A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03008056A (es) * | 2001-03-05 | 2004-10-15 | Johnson & Johnson | Composiciones farmaceuticas liquidas con sabor oculto. |
| ES2333645T3 (es) * | 2001-06-22 | 2010-02-25 | Bend Research, Inc. | Composiciones farmaceuticas de dispersiones de medicamentos y polimeros neutros. |
| CA2500218A1 (en) * | 2002-09-26 | 2004-04-08 | Yamanouchi Pharmaceutical Co., Ltd. | Drug absorptivity improving agent |
| USD529397S1 (en) | 2004-08-18 | 2006-10-03 | Gabrielle Studio, Inc. | Cosmetic container |
| TWI463998B (zh) * | 2009-12-31 | 2014-12-11 | Synmosa Biopharma Corp | Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients |
| JP6326040B2 (ja) * | 2013-02-26 | 2018-05-16 | 公益財団法人微生物化学研究会 | 新規化合物及びその製造方法、並びにその用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07189Y2 (ja) * | 1987-08-19 | 1995-01-11 | 有限会社平伊建機 | 自走行式クラッシャ− |
| JP2574489B2 (ja) * | 1988-12-17 | 1997-01-22 | 明治製菓株式会社 | ２，３―ジ置換―４―ヒドロキシキノリン誘導体及びその製法 |
| JPH05117268A (ja) * | 1991-10-22 | 1993-05-14 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物 |
| JP3117294B2 (ja) * | 1992-08-10 | 2000-12-11 | 山之内製薬株式会社 | 新規抗生物質及びその製造法 |
| EP0858450A1 (de) * | 1995-09-29 | 1998-08-19 | Pfizer Pharmaceuticals Inc. | Chinolonverbindungen zur behandlung von durch helicobacter pylori verursachten störungen |
| US6080757A (en) * | 1996-06-06 | 2000-06-27 | Pfizer Inc | Antibiotic quinolones and derivatives |
-
1998
- 1998-05-14 AT AT98919598T patent/ATE230264T1/de not_active IP Right Cessation
- 1998-05-14 WO PCT/JP1998/002133 patent/WO1998051306A1/ja not_active Ceased
- 1998-05-14 EP EP98919598A patent/EP0992241B1/de not_active Expired - Lifetime
- 1998-05-14 CA CA002290549A patent/CA2290549C/en not_active Expired - Fee Related
- 1998-05-14 AU AU72376/98A patent/AU7237698A/en not_active Abandoned
- 1998-05-14 CN CNB98805082XA patent/CN1305472C/zh not_active Expired - Fee Related
- 1998-05-14 DE DE69810474T patent/DE69810474T2/de not_active Expired - Fee Related
- 1998-05-14 ES ES98919598T patent/ES2190076T3/es not_active Expired - Lifetime
- 1998-05-14 US US09/423,924 patent/US6184230B1/en not_active Expired - Fee Related
- 1998-05-14 KR KR10-1999-7010528A patent/KR100512516B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1255853A (zh) | 2000-06-07 |
| DE69810474D1 (de) | 2003-02-06 |
| CN1305472C (zh) | 2007-03-21 |
| EP0992241B1 (de) | 2003-01-02 |
| DE69810474T2 (de) | 2003-10-30 |
| ES2190076T3 (es) | 2003-07-16 |
| CA2290549C (en) | 2007-04-17 |
| KR100512516B1 (ko) | 2005-09-06 |
| EP0992241A1 (de) | 2000-04-12 |
| KR20010012572A (ko) | 2001-02-15 |
| EP0992241A4 (de) | 2001-04-04 |
| US6184230B1 (en) | 2001-02-06 |
| AU7237698A (en) | 1998-12-08 |
| CA2290549A1 (en) | 1998-11-19 |
| WO1998051306A1 (en) | 1998-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE496048T1 (de) | Phenylcarboxamidverbindungen zur schmerzbehandlung | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| AU8531101A (en) | Immunoregulatory compounds and derivatives and methods of treating diseases therewith | |
| DE60012988D1 (en) | Taxane mit carbonaten in c-4 | |
| AU2002357191A1 (en) | Derivatives of isoindigo, indigo and indirubin and use in treating cancer | |
| FI933681A0 (fi) | Antimikrobiellt medel | |
| CA3242451A1 (en) | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| DE60018409D1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| ATE230264T1 (de) | Medizinische zusammensetzungen gegen helicobacter pylori | |
| BR9910098A (pt) | Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos | |
| SE9700244D0 (sv) | Novel antibacterial protein | |
| AR022338A1 (es) | Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal. | |
| BR0011666A (pt) | Derivado de pirrolpiridazina opticamente ativo ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso em derivado de pirrolpiridazina opticamente ativo, método para tratar ou prevenir doença e, processo para sintetizar um derivado de pirrolpiridazina opticamente ativo ou um sal farmaceuticamente aceitável do mesmo | |
| ATE212229T1 (de) | Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden | |
| NO20013480L (no) | Legemiddel for torr hud | |
| NO996117L (no) | Anordning for tilfoering av medikamenter samt behandling av virale og mikrobielle infeksjoner og taeringssyndrom | |
| BR0215070A (pt) | Métodos de tratamento de infecções bacterianas em cães e gatos | |
| ATE245151T1 (de) | Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |